Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.48 |
| ▸ | USP2 | O75604 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.46 |
| ▸ | REN | P00797 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | MMP2 | P08253 | 1/20 | 0.45 |
| ▸ | RRM1 | P23921 | 1/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24804157 | 1.00 | DPP7 (0.48) | DPP7EPHX1USP2TSHRMMP8 | |
| SCHEMBL5021624 | 1.00 | DPP7 (0.48) | DPP7EPHX1USP2TSHRMMP8 | |
| SCHEMBL5021621 | 0.94 | DPP7 (0.56) | DPP7EPHX1MMP8RRM1 | |
| SCHEMBL14341512 | 0.92 | EPHX1 (0.57) | DPP7EPHX1MMP8RRM1 | |
| SCHEMBL5021622 | 0.92 | EPHX1 (0.57) | DPP7EPHX1MMP8RRM1 | |
| SCHEMBL13924949 | 0.92 | EPHX1 (0.57) | DPP7EPHX1MMP8RRM1 | |
| SCHEMBL15856115 | 0.92 | EPHX1 (0.57) | DPP7EPHX1MMP8RRM1 | |
| SCHEMBL17853878 | 0.91 | USP2 (0.50) | DPP7EPHX1USP2TSHRMMP8 | |
| SCHEMBL17527573 | 0.89 | ALDH1A2 (0.52) | DPP7EPHX1USP2TSHRMMP8 | |
| SCHEMBL5021623 | 0.86 | TSHR (0.50) | DPP7EPHX1USP2TSHRMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220411363-A1 | PROCESS FOR PREPARING 2-METHYL-N-(2' -METHYLBUTYL)BUTANAMIDE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220411363-A1 | PROCESS FOR PREPARING 2-METHYL-N-(2' -METHYLBUTYL)BUTANAMIDE | ALKBH5, ALKBH2, ADRB2 | DPP7 2064/4885EPHX1 3227/4885USP2 887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.